Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamar Amit

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
Antioxidants & Redox Signaling|February 25, 2012
The novel multi-target iron chelating-radical scavenging compound M30 possesses beneficial effects on major hallmarks of Alzheimer's diseaseLana Kupershmidt, Tamar Amit, Orit Bar-Am, et al.
International Review of Neurobiology|October 6, 2011
Neuroprotective profile of the multitarget drug rasagiline in Parkinson's diseaseOrly Weinreb, Tamar Amit, Peter Riederer, et al.
Journal of Alzheimer'S Disease : JAD|June 18, 2010
Propargylamine containing compounds as modulators of proteolytic cleavage of amyloid-beta protein precursor: involvement of MAPK and PKC activationOrit Bar-Am, Tamar Amit, Orly Weinreb, et al.
Cellular and Molecular Neurobiology|January 18, 2013
Lithium's gene expression profile, relevance to neuroprotection A cDNA microarray studyRaymond Farah, Rola Khamisy-Farah, Tamar Amit, et al.
British Journal of Pharmacology|July 31, 2014
Molecular targets of the multifunctional iron-chelating drug, M30, in the brains of mouse models of type 2 diabetes mellitusDanit Mechlovich, Tamar Amit, Orit Bar-Am, et al.
CNS Neuroscience & Therapeutics|December 2, 2008
Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseasesSilvia A Mandel, Tamar Amit, Orly Weinreb, et al.
Journal of Neurochemistry|August 8, 2007
The neuroprotective effect of Activin A and B: implication for neurodegenerative diseasesLana Kupershmidt, Tamar Amit, Orit Bar-Am, et al.
The Journal of Nutrition|July 22, 2008
Targeting multiple neurodegenerative diseases etiologies with multimodal-acting green tea catechinsSilvia A Mandel, Tamar Amit, Limor Kalfon, et al.
Neuro-Degenerative Diseases|March 4, 2010
Low dosage of rasagiline and epigallocatechin gallate synergistically restored the nigrostriatal axis in MPTP-induced parkinsonismLydia Reznichenko, Limor Kalfon, Tamar Amit, et al.
Mechanisms of Ageing and Development|March 20, 2012
Neuroprotection by the multitarget iron chelator M30 on age-related alterations in miceLana Kupershmidt, Tamar Amit, Orit Bar-Am, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Antioxidants & Redox Signaling|February 25, 2012
The novel multi-target iron chelating-radical scavenging compound M30 possesses beneficial effects on major hallmarks of Alzheimer's diseaseLana Kupershmidt, Tamar Amit, Orit Bar-Am, et al.
International Review of Neurobiology|October 6, 2011
Neuroprotective profile of the multitarget drug rasagiline in Parkinson's diseaseOrly Weinreb, Tamar Amit, Peter Riederer, et al.
Journal of Alzheimer'S Disease : JAD|June 18, 2010
Propargylamine containing compounds as modulators of proteolytic cleavage of amyloid-beta protein precursor: involvement of MAPK and PKC activationOrit Bar-Am, Tamar Amit, Orly Weinreb, et al.
Cellular and Molecular Neurobiology|January 18, 2013
Lithium's gene expression profile, relevance to neuroprotection A cDNA microarray studyRaymond Farah, Rola Khamisy-Farah, Tamar Amit, et al.
British Journal of Pharmacology|July 31, 2014
Molecular targets of the multifunctional iron-chelating drug, M30, in the brains of mouse models of type 2 diabetes mellitusDanit Mechlovich, Tamar Amit, Orit Bar-Am, et al.
CNS Neuroscience & Therapeutics|December 2, 2008
Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseasesSilvia A Mandel, Tamar Amit, Orly Weinreb, et al.
Journal of Neurochemistry|August 8, 2007
The neuroprotective effect of Activin A and B: implication for neurodegenerative diseasesLana Kupershmidt, Tamar Amit, Orit Bar-Am, et al.
The Journal of Nutrition|July 22, 2008
Targeting multiple neurodegenerative diseases etiologies with multimodal-acting green tea catechinsSilvia A Mandel, Tamar Amit, Limor Kalfon, et al.
Neuro-Degenerative Diseases|March 4, 2010
Low dosage of rasagiline and epigallocatechin gallate synergistically restored the nigrostriatal axis in MPTP-induced parkinsonismLydia Reznichenko, Limor Kalfon, Tamar Amit, et al.
Mechanisms of Ageing and Development|March 20, 2012
Neuroprotection by the multitarget iron chelator M30 on age-related alterations in miceLana Kupershmidt, Tamar Amit, Orit Bar-Am, et al.
Pageof 9